NCT06397820

Brief Summary

The aim of the study is to evaluate the clinical implications of artificial Intelligence (AI)-assisted quantitative coronary angiography (QCA) and positron emission tomography (PET)-derived myocardial blood flow in clinically indicated patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 3, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 24, 2025

Status Verified

February 1, 2025

Enrollment Period

2.9 years

First QC Date

April 30, 2024

Last Update Submit

February 20, 2025

Conditions

Keywords

Invasive coronary angiographyCardaic positron Emission TomographyArtificial IntelligenceQuantitative Coronary Angiography

Outcome Measures

Primary Outcomes (2)

  • Correlation between diameter stenosis by AI-QCA and PET-driven RFR

    Performance of AI-QCA predicting for PET-driven RFR

    Immediate after AI-QCA and PET exams

  • Correlation between diameter stenosis by AI-QCA and PET-driven stress MBF

    Performance of AI-QCA predicting for PET-driven stress MBF

    Immediate after AI-QCA and PET exams

Secondary Outcomes (12)

  • Correlation between diameter stenosis by AI-QCA and PET-driven coronary flow reserve (CFR)

    Immediate after AI-QCA and PET exams

  • Correlation between diameter stenosis by AI-QCA and PET-driven coronary flow capacity (CFC)

    Immediate after AI-QCA and PET exams

  • Correlation between diameter stenosis by AI-QCA and PET-driven semi-quantitative markers of ischemia

    Immediate after AI-QCA and PET exams

  • All-cause death

    1 year after last patient enrollment

  • Cardiovascular death

    1 year after last patient enrollment

  • +7 more secondary outcomes

Study Arms (2)

Positive for PET-derived indexes

Patients who had decreased stress myocardial blood flow (MBF) or relative flow ratio (RFR) on PET

Device: Percutaneous coronary intervention (PCI)

Negative for PET-derived indexes

Patients who had preserved stress myocardial blood flow (MBF) or relative flow ratio (RFR) on PET

Interventions

Revascularization by percutaneous coronary intervention for vessels with decreased PET-derived flow indexes

Positive for PET-derived indexes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with suspected coronary artery disease (CAD) undergoing invasive coronary angiography (CAG) and clinically indicated for cardiac PET assessment.

You may qualify if:

  • Subject must be ≥18 years
  • Patients suspected with CAD or ischemic heart disease
  • Patients undergoing CAG and cardiac PET for evaluation of severity of coronary artery disease

You may not qualify if:

  • Poor imaging quality of CAG and PET which were not available for core-lab analysis
  • Chronic total occlusion
  • Time interval was more than \>3 months between CAG and PET
  • History of coronary artery bypass grafting
  • History of acute myocardial infarction or recent myocardial infarction
  • Heart failure (left ventricular ejection fraction \<40%)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chonnam National University Hospital

Gwangju, 61469, South Korea

Location

MeSH Terms

Conditions

Coronary Artery DiseaseCoronary Stenosis

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Sang-Geon Cho, MD, PhD

    Chonnam National University Hospital

    PRINCIPAL INVESTIGATOR
  • Seung Hun Lee, MD, PhD

    Chonnam National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 30, 2024

First Posted

May 3, 2024

Study Start

September 1, 2021

Primary Completion

July 31, 2024

Study Completion

December 31, 2024

Last Updated

February 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

After publication of main paper, de-identified data will be shared upon reasonable requests after discussion by Executive Committee.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After publication of main paper.
Access Criteria
Executive Committee will discuss to share the de-identified data upon reasonable requests.

Locations